CLGM
JAZZ icon

Capitolis Liquid Global Markets’s Jazz Pharmaceuticals JAZZ Stock Holding History

Capitolis Liquid Global Markets’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.29M Sell
28,000
-32,100
-53% -$5.61M 0.03% 248
2025
Q4 		$10.2M Buy
+60,100
New +$9.21M 0.06% 148

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Capitolis Liquid Global Markets's JAZZ Position: Q1 2026 in Review

Capitolis Liquid Global Markets reduced its Jazz Pharmaceuticals (JAZZ) stake by 53% in Q1 2026, selling an estimated $5.61M and leaving 28,000 shares worth $5.29M. The position accounts for 0.03% of the portfolio, ranked #248.

Capitolis Liquid Global Markets first reported a position in JAZZ in Q4 2025 and has held it in 2 quarters since. The position peaked at $10.2M in Q4 2025. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Capitolis Liquid Global Markets held 28,000 shares of Jazz Pharmaceuticals worth $5.29M as of Q1 2026.
  • Capitolis Liquid Global Markets sold 32,100 Jazz Pharmaceuticals shares in Q1 2026, an estimated $5.61M.
  • Jazz Pharmaceuticals made up 0.03% of Capitolis Liquid Global Markets's portfolio in Q1 2026, its #248 holding.
  • Capitolis Liquid Global Markets first reported a position in Jazz Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Capitolis Liquid Global Markets's Jazz Pharmaceuticals position peaked at $10.2M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q1 2026, filed 15 May 2026.